Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSTVN
āļāļ·āđāļāļāļĢāļīāļĐāļąāļStevanato Group SpA
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 16, 2021
āļāļĩāļāļĩāđāļStevanato (Franco)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ5521
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJul 16
āļāļĩāđāļāļĒāļđāđPiombino Dese (Pd) Via Molinella, 17
āđāļĄāļ·āļāļPIOMBINO DESE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻItaly
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ35017
āđāļāļĢāļĻāļąāļāļāđ390499318173
āđāļ§āđāļāđāļāļāđhttps://www.stevanatogroup.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSTVN
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 16, 2021
āļāļĩāļāļĩāđāļStevanato (Franco)
Mr. Mauro Stocchi
Chief Business Officer
Mr. Fabrizio Bonanni
Independent Director
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Mr. Riccardo Butta
President, Americas
Mr. Alvise Spinazzi
Director
Mr. Luciano Santel
Independent Director
Mr. Franco Stevanato
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
Mr. Fabio Buttignon, CPA
Independent Director
Dr. Donald E. (Don) Morel, Jr.
Dr. Donald E. (Don) Morel, Jr.
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Mauro Stocchi
Chief Business Officer
Mr. Fabrizio Bonanni
Independent Director
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Mr. Riccardo Butta
President, Americas
Mr. Alvise Spinazzi
Director
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
53.45M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2025 going ex on Jun 05, 2025
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022